1st Quarter - Report

LINCOLN POLICY GROUP for PFIZER

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.

LobbyistCovered position, as disclosed
DAN ELLING —
COOKAB HASHEMI New Chief of Staff, Rep. Raul Ruiz; Chief of Staff, Rep. Jackie Speier; Deputy Chief of Staff, Rep. Mark Udall; Spec Assistant, Sen. Evan Bayh; Confidential Assistant, Office of Rural Development, USDA; Spec Assistant, Ofc of Political Affairs, White Hse
ROBERT HOLIFIELD —
HANNAH LAMBIOTTE SMITH —
BLANCHE LINCOLN —
COLIN ROSKEY —
THOMAS A SCULLY —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3 (117th), S. 2543 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.